Interpace Biosciences, Inc. financial data

Symbol
IDXG on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
Waterview Plaza, Suite 310, 2001 Route 46, Parsippany, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Interpace Diagnostics Group, Inc. (to 11/1/2019), PDI INC (to 12/22/2015), PROFESSIONAL DETAILING INC (to 11/13/2002)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 61 % -31.6%
Quick Ratio 6.94 % -18.6%
Debt-to-equity -45.3 % +10.6%
Return On Equity -4.59 % -119%
Return On Assets 21.4 %
Operating Margin -63.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.39M shares +1.86%
Common Stock, Shares, Outstanding 4.38M shares +1.51%
Entity Public Float 3.79M USD -67.3%
Common Stock, Value, Issued 406K USD +0.25%
Weighted Average Number of Shares Outstanding, Basic 4.38M shares +1.51%
Weighted Average Number of Shares Outstanding, Diluted 4.4M shares +1.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.68M USD
Revenue from Contract with Customer, Excluding Assessed Tax 41.7M USD +11.5%
Cost of Revenue 17.1M USD +15.3%
Research and Development Expense 584K USD -3.15%
Selling and Marketing Expense 11M USD +17.9%
General and Administrative Expense 8.36M USD -20.4%
Operating Income (Loss) 4.43M USD +467%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.01M USD +436%
Income Tax Expense (Benefit) 17K USD +467%
Net Income (Loss) Attributable to Parent 2.81M USD +1078%
Earnings Per Share, Basic 0.65 USD/shares +1075%
Earnings Per Share, Diluted 0.64 USD/shares +1075%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.02M USD -60.2%
Accounts Receivable, after Allowance for Credit Loss, Current 6.21M USD +12.2%
Inventory, Net 1.23M USD +4.59%
Other Assets, Current 1.94M USD -18%
Assets, Current 10.2M USD -21.6%
Property, Plant and Equipment, Net 1.13M USD +85.8%
Operating Lease, Right-of-Use Asset 1.64M USD -21.8%
Goodwill 8.43M USD 0%
Other Assets, Noncurrent 45K USD 0%
Assets 13M USD -18.6%
Accounts Payable, Current 1.76M USD +4.26%
Employee-related Liabilities, Current 1.24M USD +10.3%
Liabilities, Current 19M USD +40.3%
Long-term Debt and Lease Obligation 1.75M USD -41.1%
Operating Lease, Liability, Noncurrent 1.29M USD -21.9%
Other Liabilities, Noncurrent 5.15M USD +5.82%
Liabilities 25.5M USD -19.5%
Retained Earnings (Accumulated Deficit) -246M USD +1.13%
Stockholders' Equity Attributable to Parent -59M USD +5.11%
Liabilities and Equity 13M USD -18.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -58K USD -105%
Net Cash Provided by (Used in) Financing Activities -600K USD -100%
Net Cash Provided by (Used in) Investing Activities -28K USD +56.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.49M shares +2.19%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -686K USD -189%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.02M USD -60.2%
Deferred Tax Assets, Valuation Allowance 38.7M USD +1.04%
Operating Lease, Liability 1.61M USD -23.2%
Payments to Acquire Property, Plant, and Equipment 28K USD -56.9%
Lessee, Operating Lease, Liability, to be Paid 2.04M USD -25.9%
Property, Plant and Equipment, Gross 3.33M USD +16.6%
Operating Lease, Liability, Current 319K USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year Two 500K USD +11.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 450K USD -21.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 438K USD -34.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 550K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 26.4M USD -1.06%
Unrecognized Tax Benefits 877K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 275K USD -66.7%
Amortization of Intangible Assets 900K USD -30.8%
Depreciation, Depletion and Amortization 356K USD -54.4%
Deferred Tax Assets, Net of Valuation Allowance 21K USD -96.8%
Share-based Payment Arrangement, Expense 413K USD -55.7%